Industry Report – July & August 2026

The Industry Report in reply-all shares a selection of recent news featuring UPMC Enterprises, our portfolio companies, and partnerships.

This edition includes stories about Latigo Biotherapeutics’ Nasdaq debut, BrainCheck’s new population analytics program, the launch of Sempre’s generics initiatve, and media coverage of the CCM’s latest research report.

Keep an eye on UPMC Enterprises’ News webpage for the latest industry stories.

UPMC Enterprises

UPMC, KLAS Research study examines AI adoption trends, governance barriers | Fierce Healthcare

Most health systems lack dedicated AI testing platforms: Report | Becker’s Health IT

CCM and KLAS Research Report: 63% of Health Systems Lack Advanced AI Strategy Frameworks | HIT Consultant

Abridge

Abridge and Kaiser Permanente debut Care Signals | Becker’s Hospital Review

BrainCheck

BrainCheck® Launches Population Analytics to Scale Proactive Cognitive Care | BusinessWire

BrainCheck Selected for Three Poster Presentations at the 2026 Alzheimer’s Association International Conference | BusinessWire

Carta Healthcare

Clinical Data Fidelity: The Real Blindspot in Healthcare AI Strategy | HIT Consultant

Carta Healthcare Wins Gold in the 2026 Stevie® Awards for Technology Excellence | Carta Healthcare

Clearsense

HIStalk Interviews Jason Rose, CEO, Clearsense | HIStalk

Elektra Health

Women’s Health: A Market Ready for Transformation | Deloitte US

Koda Health

Koda Health Appoints Graham Gardner, Founder of Kyruus Health, to Board of Directors | EIN Presswire

Latigo Biotherapeutics

Latigo Biotherapeutics Announces Pricing of Upsized $345.6 Million Initial Public Offering | Globe Newswire

Latigo Biotherapeutics Appoints Todd Smith to its Board of Directors | BusinessWire

Optain

Whitepaper: Medical Devices in the AI Era | Aegis Ventures

Penguin Ai

Why Build Vs. Buy Is The Wrong Question For Healthcare AI | Forbes

Fawad Butt, CEO and Co-Founder of Penguin Ai – Interview Series | Unite.AI

Sempre Health

Sempre Health Launches Generics, Extending Its Adherence Platform to a Member’s Full Chronic Disease Regimen | PR Newswire

Independence Blue Cross program with Sempre Health helps members save more than $1.1 million on prescription drugs since 2022 | Independence News

Ultromics

New AHA report highlights Ultromics’ AI tool’s benefit in earlier heart failure diagnosis | Medical Device Network